featured
Validation of Diagnostic Tests Based on BC-116 and BC-106 Urine Peptide Biomarkers for Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients
Br. J. Cancer 2022 Oct 03;[EPub Ahead of Print], L Mengual, M Frantzi, M Mokou, M Ingelmo-Torres, M Vlaming, AS Merseburger, MC Roesch, Z Culig, A Alcaraz, A Vlahou, H Mischak, AG Van der HeijdenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.